{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:30:23Z","timestamp":1793932223323,"version":"4.8.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"Abstract<\/jats:title>\n \n Background:<\/jats:title>\n Nail psoriasis is a common and challenging-to-treat manifestation of psoriasis. The efficacy of several medications has been studied in treating nail psoriasis with different results.<\/jats:p>\n <\/jats:sec>\n \n Aim and Objective:<\/jats:title>\n This trial assessed the therapeutic efficacy and safety of intralesional methotrexate injection compared to intralesional triamcinolone injection for nail psoriasis.<\/jats:p>\n <\/jats:sec>\n \n Patients and Methods:<\/jats:title>\n Seventeen patients (69 nails) were recruited in this investigator-blind, randomized, controlled trial, and 13 patients (65 nails) completed the study. The severity of the disease was evaluated by the modified Nail Psoriasis Severity Index (mNAPSI) before starting treatment, after each injection, and 8 weeks after the last injection. Thirty-three nails were randomly treated with methotrexate and 32 nails with triamcinolone. A volume of 0.1 mL of the diluted (5 mg\/mL) triamcinolone (0.5 mg) or 0.05 mL of methotrexate (1.25 mg) was injected at each point every 3 weeks for four sessions. (Clinical trial registry: Iranian Registry of Clinical Trials. [ID: IRCT20140212016557N7]).<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n Both interventions significantly reduced the mNAPSI score (\n P<\/jats:italic>\n < 0.001). The percentage of reduction of mNAPSI score was more in the triamcinolone-treated nails at the end of treatment (\n P<\/jats:italic>\n = 0.015), but not significantly different in the 8-week follow-up (\n P<\/jats:italic>\n = 0.906). Deterioration of the mNAPSI score was seen only in the triamcinolone group at the end of 8 weeks after discontinuation of treatment (\n P<\/jats:italic>\n = 0.01).\n <\/jats:p>\n <\/jats:sec>\n \n Limitations:<\/jats:title>\n A relatively small sample size, lack of prolonged follow-up, and absence of response assessment of the nail matrix and bed separately.<\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n Intralesional methotrexate is an effective and safe treatment for nail psoriasis, with similar efficacy to intralesional triamcinolone. Methotrexate showed more persistent efficacy compared to triamcinolone.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/idoj.idoj_1017_24","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T07:00:09Z","timestamp":1792393209000},"page":"822-827","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of the Efficacy of Intralesional Methotrexate and Triamcinolone in the Treatment of Nail Psoriasis: A Randomized, Investigator-Blind, Controlled Trial"],"prefix":"10.4103","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8869-266X","authenticated-orcid":false,"given":"Kourosh","family":"Ahmadi","sequence":"first","affiliation":[{"name":"Department of Dermatology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8773-0019","authenticated-orcid":false,"given":"Mozhdeh","family":"Sepaskhah","sequence":"additional","affiliation":[{"name":"Department of Dermatology, School of Medicine, Molecular Dermatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6239-2925","authenticated-orcid":false,"given":"Zahra","family":"Bagheri","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0984-4704","authenticated-orcid":false,"given":"Roya","family":"Radanfar","sequence":"additional","affiliation":[{"name":"Department of Dermatology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,19]]},"reference":[{"key":"R1-20261106","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ad.2022.01.006","article-title":"Nail psoriasis","volume":"113","author":"Canal-Garc\u00eda","year":"2022","journal-title":"Actas Dermosifiliogr"},{"key":"R2-20261106","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1111\/jdv.12368","article-title":"Nail psoriasis, the unknown burden of disease","volume":"28","author":"Klaassen","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R3-20261106","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4103\/idoj.IDOJ_280_18","article-title":"A Compendium of intralesional therapies in nail disorders","volume":"9","author":"Grover","year":"2018","journal-title":"Indian Dermatol Online J"},{"key":"R4-20261106","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.2147\/CCID.S380218","article-title":"The Anti-psoriatic efficacy and safety profile of topical and intralesional methotrexate: A literature review","volume":"15","author":"Chaiyabutr","year":"2022","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"R6-20261106","doi-asserted-by":"crossref","first-page":"e14404","DOI":"10.1111\/dth.14404","article-title":"Intralesional methotrexate in dermatology: Diverse indications and practical considerations","volume":"34","author":"Searle","year":"2021","journal-title":"Dermatol Ther"},{"key":"R7-20261106","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s13555-021-00523-x","article-title":"Nail psoriasis: A review of effective therapies and recommendations for management","volume":"11","author":"Hadeler","year":"2021","journal-title":"Dermatol Ther (Heidelb)"},{"key":"R8-20261106","doi-asserted-by":"crossref","first-page":"e15660","DOI":"10.1111\/dth.15660","article-title":"Topical calcipotriol combined with urea 20% versus intralesional injection of triamcinolone acetonide, 5-fluorouracil, and methotrexate in the treatment of nail psoriasis: A comparative study","volume":"35","author":"Abdelmeniem","year":"2022","journal-title":"Dermatol Ther"},{"key":"R9-20261106","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/09546634.2018.1476647","article-title":"A randomized comparison of efficacy and safety of intralesional triamcinolone injection and clobetasol propionate ointment for psoriatic nails","volume":"30","author":"Boontaveeyuwat","year":"2019","journal-title":"J Dermatolog Treat"},{"key":"R10-20261106","first-page":"145","article-title":"The Comparison of the efficacy and safety of intralesional triamcinolone acetonide and methotrexate injections for the treatment of fingernail psoriasis","volume":"71","author":"\u00dcst\u00fcner","year":"2018","journal-title":"J Ankara Univ Fac Med"},{"key":"R11-20261106","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/ced.15110","article-title":"A pilot study of intralesional methotrexate injections versus triamcinolone acetonide in patients affected by nail matrix psoriasis","volume":"47","author":"Starace","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"R12-20261106","first-page":"123","article-title":"The modified nail psoriasis severity index: Validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis","volume":"34","author":"Cassell","year":"2007","journal-title":"J Rheumatol"},{"key":"R13-20261106","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-5945-4-8","article-title":"DLQI scores in vitiligo: Reliability and validity of the Persian version","volume":"4","author":"Aghaei","year":"2004","journal-title":"BMC Dermatol"},{"key":"R14-20261106","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1590\/abd1806-4841.20198170","article-title":"Nail psoriasis treated with intralesional methotrexate infiltration","volume":"94","author":"Duarte","year":"2019","journal-title":"An Bras Dermatol"},{"key":"R15-20261106","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4103\/ijdvl.IJDVL_73_16","article-title":"Intramatricial injections for nail psoriasis: An open-label comparative study of triamcinolone, methotrexate, and cyclosporine","volume":"84","author":"Mittal","year":"2018","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R16-20261106","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s13555-018-0261-2","article-title":"A case of nail psoriasis successfully treated with intralesional methotrexate","volume":"8","author":"Mokni","year":"2018","journal-title":"Dermatol Ther (Heidelb)"},{"key":"R17-20261106","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000323004","article-title":"Nail psoriasis successfully treated with intralesional methotrexate: Case report","volume":"222","author":"Saricaoglu","year":"2011","journal-title":"Dermatology"},{"key":"R18-20261106","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jaad.2020.04.159","article-title":"Treatment of nail psoriasis with intramatrical methotrexate: An uncontrolled prospective study of 20 patients","volume":"84","author":"Choudhary","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"R19-20261106","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/DSS.0000000000003418","article-title":"Fractional CO2 laser-assisted delivery versus intralesional injection of methotrexate in psoriatic nails","volume":"48","author":"Alakad","year":"2022","journal-title":"Dermatol Surg"}],"container-title":["Indian Dermatology Online Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.idoj_1017_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:00:39Z","timestamp":1793930439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.idoj_1017_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,19]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/idoj.idoj_1017_24","relation":{},"ISSN":["2229-5178","2249-5673"],"issn-type":[{"value":"2229-5178","type":"print"},{"value":"2249-5673","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,19]]},"assertion":[{"value":"2024-10-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}